OOIR: Observatory of International Research

Papers

(The H4-Index of RSC Medicinal Chemistry is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives as potential antitubercular agents	112
Back cover	109
Back cover	105
Inside front cover	99
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibition	92
4-Trifluoromethyl bithiazoles as broad-spectrum antimicrobial agents for virus-related bacterial infections or co-infections	89
Designing halogen-free metal–phenolic imidazolium poly(ionic liquids) with multi-functional antibacterial, anti-inflammatory and cell proliferation properties for infected wounds	77
Beta-cyclodextrin formulation of a disulfide-bond disrupting agent for improved systemic exposure	74
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold	71
Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators	70
In vivo demonstration of enhanced mRNA delivery by cyclic disulfide-containing lipid nanoparticles for facilitating endosomal escape	69
Oxadiargyl analogs as potent inhibitors of Toxoplasma gondii protoporphyrinogen oxidase	62
Design, synthesis and structure–activity relationship analysis of dibenzodiazepinone derivatives against Osimertinib resistant NSCLC	44
New azole derivatives linked to indole/indoline moieties combined with FLC against drug-resistant Candida albicans	43
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking	43
Unusual Ni⋯Ni interaction in Ni(ii) complexes as potential inhibitors for the development of new anti-SARS-CoV-2 Omicron drugs	42
Exploring the potential of tamoxifen-based copper(ii) dichloride in breast cancer therapy	42
N-Arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-2	39
Design, synthesis, in vitro and in silico evaluation of indole-based tetrazole derivatives as putative anti-breast cancer agents	38
The effects of bioisostere substitution on the antimicrobial and physicochemical properties of supramolecular self-associating amphiphiles	38
ATP-competitive inhibitors for cancer treatment – kinases and the world beyond	37
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregation	36
Recent advances of phenotypic screening strategies in the application of anti-influenza virus drug discovery	36
Emerging opportunities in the rewiring of biology through proximity inducing small molecules	32
Biocompatible glycolipid derived from bhilawanol as an antibiofilm agent and a promising platform for drug delivery	32

Cytotoxicity of phosphoramidate, bis-amidate and cycloSal prodrug metabolites against tumour and normal cells	31
Integrated computational screen and validation of thalidomide-based PROTACs targeting SARS-CoV-2 main protease	30
Research progress of anticancer drugs targeting CDK12	29
Emerging cellular uptake mechanisms of bRo5 PROTACs	29
Integrating computational and experimental chemical biology revealed variable anticancer activities of phosphodiesterase isoenzyme 5 inhibitors (PDE5i) in lung cancer	29